KANSAS CITY, Kan., PRNewswire/ -- Two Kansas women who took Lipitor to reduce their cholesterol levels and later developed type 2 diabetes have filed lawsuits against Lipitor's maker, Pfizer. The announcement was made by the attorney filing the suit, Robert K. Jenner, who is with the Kansas City, Kan.-based firm of Janet, Jenner & Suggs, LLC.
Few treatments for type 1 diabetes have been as elusive and long-promised as inhalable insulin. The concept has always sounded remarkable: Instead of jabbing themselves with needles, type 1s (and insulin-using type 2s) could take a quick puff on an inhaler to get a dose of insulin.
Health experts are unanimous that obesity or being overweight are major factors in the onset of type 2 diabetes. So it's no surprise that researchers here and abroad are working to develop weight-loss drugs that can help people shed pounds and lessen their susceptibility to diabetes.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health.
Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.